Related Experiment Video
Updated: Aug 5, 2026
07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
Designing a Multi-Epitope Vaccine Candidate Against Rhodococcus equi Based on the Bioinformatics Technique
Shiwen Gao1, Guoqing Li1, Xiangyu Wang1
1Xinjiang Key Laboratory of New Drug Research and Development for Herbivores, College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi 830052, China.
Veterinary Sciences
|July 28, 2026
Summary
This study designed novel multi-epitope vaccines against multidrug-resistant Rhodococcus equi using bioinformatics. The V3 and V4 constructs showed strong binding affinity to equine MHC molecules, demonstrating potential for foal protection.
Area of Science:
- Veterinary immunology
- Bioinformatics
- Vaccine development
Background:
- Multidrug-resistant Rhodococcus equi causes severe infections in foals, leading to significant economic losses in the equine industry.
- The lack of a commercial vaccine for R. equi necessitates the development of new therapeutic strategies.
- Antigenic epitope identification and prioritization are crucial for designing effective multi-epitope vaccines.
Purpose of the Study:
- To identify and prioritize antigenic epitopes from R. equi for the rational design of a multi-epitope vaccine.
- To construct and evaluate novel multi-epitope vaccine candidates (V1-V6) with potential to induce protective immunity in foals.
- To assess the binding affinity and stability of selected vaccine constructs with equine MHC molecules.
Main Methods:
- Bioinformatic analysis using ABCPred, NetMHCpan EL, and IEDB servers to select MHC-I and MHC-II epitopes.
- Construction and in silico evaluation of six multi-epitope vaccine constructs (V1-V6).
- Molecular docking and dynamics simulations (HDOCK, Gromacs) to assess interactions with equine MHC molecules (EQCA-I, EQCA-II).
- Prokaryotic expression and preliminary immunogenicity testing in mice.
Main Results:
- Twenty-seven MHC-I and nine MHC-II epitopes were identified from five R. equi vaccine candidates.
- Two multi-epitope constructs, V3 and V4, demonstrated strong binding affinity and stable conformations with equine MHC molecules.
- Prokaryotic expression of V3 and V4 proteins was successful, and preliminary mouse immunization elicited antigen-specific IgG responses.
Conclusions:
- The V3 and V4 multi-epitope vaccine constructs show theoretical potential for inducing humoral and cellular immunity against R. equi in foals.
- The study provides a strong theoretical basis for developing R. equi vaccines and a reference for designing vaccines against other resistant pathogens.
- Further validation in equine models is necessary to confirm efficacy in preventing R. equi infections.
